Albert J. Chang, M.D., Ph.D.
Dr. Albert Chang specializes in radiation therapy for treatment of genitourinary malignancies, gastrointestinal malignancies, and gynecologic malignancies. He has expertise in modern radiation techniques such as stereotactic body radiotherapy, CyberKnife radiosurgery, brachytherapy, and intensity modulated radiation therapy.
Dr. Chang received his Ph.D. in molecular medicine and his M.D. from Boston University School of Medicine in 2007. He completed his residency in radiation oncology at the Washington University School of Medicine. His research interests are in the development of molecular imaging probes and targeted therapies. He has developed multiple imaging agents with the ability to characterize tumors at the cellular level. These imaging agents have the potential to be used for defining disease extent, predicting treatment response, and optimizing therapy. He is also involved in the design of clinical trials investigating the advanced imaging technologies, radiation therapy techniques, and targeted drug therapies that allow for the maximization of therapeutic effect while minimizing treatment side effects.
|1997||UC Davis||BS (SCL)||Biochemistry|
|2007||Boston University School of Medicine, Boston, MA||MD/PhD|
|2008||Kaiser Permanente Oakland, Oakland, CA||Internship|
|2012||Washington University School of Medicine, Saint-Louis, MO||Resident||Radiation Therapy|
|2012-present||UCSF||Assistant Professor in Residence||Radiation Oncology|
Awards & Honors
|1997||Phi Beta Kappa Honor Society|
|1998||Tsai Foundation Medical Student Scholarship|
|2004||Henry I. Russek Student Research Achiement|
|2005||Karin Grunenbaum Cancer Research Foundation Grant|
|2008-2012||American Board of Radiology, Leonard B. Holman Research Pathway Resident Award|
|2010||American Radium Society Travel Grant Award|
|2010||National Cancer Care Network (NCCN) Fellow|
|2011||ASTRO Cancer Imaging and Radiation Therapy Symposium Travel Grant|
|2011||Society of Nuclear Medicine Annual Meeting Travel|
|2011||Seattle Prostate Institute Brachytherapy Course|
|2011||American Association for Cancer Research Molecular Biology in Clinical Oncology Workshop|
|2011||Radiation Therapy Oncology Group/American College of Radiology Fellowship|
|2011||RSNA Research Resident Fellow Grant|
Garsa AA, Chang AJ, DeWees T, Spencer CR, Adkins DR, Dehdashti F, Gay H, Thorstad WL.Prognostic Value of 18F-FDG PET Metabolic Parmaters in Oropharyngeal Squamous Cell Carcinoma. J Radiat Oncol. 2012 Sept 13 [Epub ahead of print].
Chang AJ, Roach M 3rd. Radium-223: down to the bone, and less is more. Oncology (Williston Park). 2012 Apr;26(4):342, 344.
Chang AJ, Richardson S, Grigsby PW, Schwarz JK. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):263-9.
Chang AJ, De Silva R, Lapi S. ImmunoPET of Her-2/neu expression with 89Zr-radiolabeled trastuzumab. Accepted to Pharmaceuticals.
Chang AJ, De Silva R, Lapi S. In Vivo PET imaging of differential EGFR expression with 89Zr-radiolabled panitumumab. Accepted to Molecular Imaging and Biology.
Chang AJ, Zhao H, Moore K, Taylor M, Zoberi I, Powell SN, Klein E. Image Guidance for External Beam Partial Breast Irradiation. Practical Radiation Oncology. 2011 In Press
Chang AJ, Dehdashti F, Bradley, JD. The Role of Positron Emission Tomography for Non-Small Cell Lung Cancer. Practical Radiation Oncology. 2011 In Press.
Chang AJ, Bradley JD., Clinical Perspectives on Dose Escalation for Non-Small-Cell Lung Cancer. Clinical Lung Cancer. 2010 Sep. 1;11(5):299-302.
Myerson RJ, Outlaw ED, Chang A, Birnbaum EH, Fleshman JW, Grigsby PW, Kodner IJ, Malayapa RS, Mutch MG, Parikh P, Picus J, Tan BR. Radiotherapy for Epidermoid Carcinoma of the Anus: Thirty Years’ Experience. Int J Radiat Biol Phys. 2009 Oct. 1;75(2):428-35.